# A Pilot Study to Assess Treatment of Patients With Homogeneous Emphysema Using Sequential Segmental Bronchoscopic Thermal Vapor Ablation (NEXT STEP)

> **NCT03670121** · NA · COMPLETED · sponsor: **Uptake Medical Technology, Inc.** · enrollment: 11 (actual)

## Conditions studied

- Emphysema or COPD

## Interventions

- **DEVICE:** Bronchoscopic Thermal Vapor Ablation (BTVA)

## Key facts

- **NCT ID:** NCT03670121
- **Lead sponsor:** Uptake Medical Technology, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-08-28
- **Primary completion:** 2020-06-12
- **Final completion:** 2020-06-12
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2021-11-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03670121

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03670121, "A Pilot Study to Assess Treatment of Patients With Homogeneous Emphysema Using Sequential Segmental Bronchoscopic Thermal Vapor Ablation (NEXT STEP)". Retrieved via AI Analytics 2026-06-11 from https://api.ai-analytics.org/clinical/NCT03670121. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*